BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 32128931)

  • 1. Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter-defibrillators.
    Ishida Y; Payne JE; Field ME; Gold MR
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1195-1201. PubMed ID: 32128931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience.
    Migliore F; Schiavone M; Pittorru R; Forleo GB; De Lazzari M; Mitacchione G; Biffi M; Gulletta S; Kuschyk J; Dall'Aglio PB; Rovaris G; Tilz R; Mastro FR; Iliceto S; Tondo C; Di Biase L; Gasperetti A; Tarzia V; Gerosa G
    Int J Cardiol; 2024 Apr; 400():131807. PubMed ID: 38272130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electromagnetic interference from left ventricular assist devices detected in patients with implantable cardioverter-defibrillators.
    Sheldon SH; Jazayeri MA; Pierpoline M; Mohammed M; Parikh V; Robinson A; Noheria A; Haglund N; Sauer AJ; Reddy YM
    J Cardiovasc Electrophysiol; 2022 Jan; 33(1):93-101. PubMed ID: 34837431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.
    Black-Maier E; Lewis RK; Rehorn M; Loungani R; Friedman DJ; Frazier-Mills C; Jackson KP; Atwater BD; Milano CA; Schroder JN; Pokorney SD; Piccini JP
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1509-1518. PubMed ID: 32275340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troubleshooting electromagnetic interference in a patient with centrifugal flow left ventricular assist device and subcutaneous implantable cardioverter defibrillator.
    Ahmed AS; Patel PJ; Bagga S; Gilge JL; Schleeter T; Lakhani BA; Ravichandran AK; Donnelley S; Allavatam V; Prystowsky EN; Padanilam BJ
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):477-481. PubMed ID: 29364552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous implantable cardioverter-defibrillator troubleshooting in patients with a left ventricular assist device: A case series and systematic review.
    Black-Maier E; Lewis RK; Barnett AS; Pokorney SD; Sun AY; Koontz JI; Daubert JP; Piccini JP
    Heart Rhythm; 2020 Sep; 17(9):1536-1544. PubMed ID: 32304733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electromagnetic interference of automatic implantable cardioverter defibrillator and HeartWare left ventricular assist device.
    Labedi MR; Alharethi R; Kfoury AG; Budge D; Bruce R; Rasmusson B; Bunch TJ
    ASAIO J; 2013; 59(2):136-9. PubMed ID: 23438775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electromagnetic interference from left ventricular assist device in patients with transvenous implantable cardioverter-defibrillator.
    Khetarpal BK; Lee JZ; Javaid AI; Mi L; Venepally NR; Narasimhan B; Hardaway BW; Cha YM; Kusumoto F; Mulpuru SK; Srivathsan K
    Pacing Clin Electrophysiol; 2021 Jul; 44(7):1163-1175. PubMed ID: 33977542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices.
    Yalcin YC; Kooij C; Theuns DAMJ; Constantinescu AA; Brugts JJ; Manintveld OC; Yap SC; Szili-Torok T; Bogers AJJC; Caliskan K
    Europace; 2020 Apr; 22(4):584-587. PubMed ID: 32003803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of electromagnetic interference between HeartMate 3 LVAD and implantable cardioverter defibrillator.
    Sehatbakhsh S; Kushnir A; Kabach M; Kolek M; Chait R; Ghumman W
    Pacing Clin Electrophysiol; 2018 Feb; 41(2):218-220. PubMed ID: 28976004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous implantable cardioverter-defibrillator noise following left ventricular assist device implantation.
    Khetarpal BK; Javaid A; Lee JZ; Kusumoto F; Mulpuru SK; Sorajja D; Cha YM; Srivathsan K
    J Arrhythm; 2023 Apr; 39(2):198-206. PubMed ID: 37021015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device-device interaction between cardiac implantable electronic devices and continuous-flow left ventricular assist devices.
    Tanawuttiwat T; Das MK; Miller JM; Guglin ME
    Heart Rhythm; 2023 Jun; 20(6):918-926. PubMed ID: 36863637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience.
    Khazen C; Magnusson P; Flandorfer J; Schukro C
    Cardiol J; 2019; 26(5):543-549. PubMed ID: 29718532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in eligibility for a subcutaneous cardioverter-defibrillator after implantation of a left ventricular assist device-A prospective analysis.
    Zormpas C; Mueller-Leisse J; Hohmann S; Eiringhaus J; Hillmann HAK; Schmitto JD; Veltmann C; Duncker D
    PLoS One; 2023; 18(4):e0284419. PubMed ID: 37071637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electromagnetic interference between implantable cardiac devices and continuous-flow left ventricular assist devices: a review.
    Gordon JS; Maynes EJ; O'Malley TJ; Pavri BB; Tchantchaleishvili V
    J Interv Card Electrophysiol; 2021 Jun; 61(1):1-10. PubMed ID: 33433742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
    Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel screening tool to unmask potential interference between S-ICD and left ventricular assist device.
    Zormpas C; Eiringhaus J; Hillmann HAK; Hohmann S; Müller-Leisse J; Schmitto JD; Veltmann C; Duncker D
    J Cardiovasc Electrophysiol; 2020 Dec; 31(12):3286-3292. PubMed ID: 33017069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-end.
    Noel A; Ploux S; Bulliard S; Strik M; Haeberlin A; Welte N; Marchand H; Klotz N; Ritter P; Haïssaguerre M; Bordachar P
    Heart Rhythm; 2020 Jan; 17(1):66-74. PubMed ID: 31295585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.